Nappi, A.G.; Ferrari, C.; Mammucci, P.; Rubini, D.; Lavelli, V.; Sardaro, A.; Pisani, A.R.; Rubini, G.
[18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients. Cancers 2022, 14, 1461.
https://doi.org/10.3390/cancers14061461
AMA Style
Nappi AG, Ferrari C, Mammucci P, Rubini D, Lavelli V, Sardaro A, Pisani AR, Rubini G.
[18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients. Cancers. 2022; 14(6):1461.
https://doi.org/10.3390/cancers14061461
Chicago/Turabian Style
Nappi, Anna Giulia, Cristina Ferrari, Paolo Mammucci, Dino Rubini, Valentina Lavelli, Angela Sardaro, Antonio Rosario Pisani, and Giuseppe Rubini.
2022. "[18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients" Cancers 14, no. 6: 1461.
https://doi.org/10.3390/cancers14061461
APA Style
Nappi, A. G., Ferrari, C., Mammucci, P., Rubini, D., Lavelli, V., Sardaro, A., Pisani, A. R., & Rubini, G.
(2022). [18F]Fluciclovine PET/CT Improves the Clinical Management of Early Recurrence Prostate Cancer Patients. Cancers, 14(6), 1461.
https://doi.org/10.3390/cancers14061461